Cargando…
The Association between Use of ICS and Psychiatric Symptoms in Patients with COPD—A Nationwide Cohort Study of 49,500 Patients
Psychiatric side effects are well known from treatment with systemic corticosteroids. It is, however, unclear whether inhaled corticosteroids (ICS) have psychiatric side effects in patients with COPD. We conducted a nationwide cohort study in all Danish COPD outpatients who had respiratory medicine...
Autores principales: | Jordan, Alexander, Sivapalan, Pradeesh, Eklöf, Josefin, Vestergaard, Jakob B., Meteran, Howraman, Saeed, Mohamad Isam, Biering-Sørensen, Tor, Løkke, Anders, Seersholm, Niels, Jensen, Jens Ulrik Stæhr |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8533368/ https://www.ncbi.nlm.nih.gov/pubmed/34680609 http://dx.doi.org/10.3390/biomedicines9101492 |
Ejemplares similares
-
Treatment Response Biomarkers in Asthma and COPD
por: Meteran, Howraman, et al.
Publicado: (2021) -
Roflumilast in Severely Ill Patients with Chronic Obstructive Pulmonary Disease with Frequent Exacerbations: Risk of Pneumonia Hospitalization and Severe Exacerbations
por: Alispahic, Imane Achir, et al.
Publicado: (2020) -
Depressive symptoms among patients with COPD according to smoking status: a Danish nationwide case–control study of 21 184 patients
por: Vestergaard, Jakob Hedemark, et al.
Publicado: (2020) -
Systemic Corticosteroids and the Risk of Venous Thromboembolism in Patients with Severe COPD: A Nationwide Study of 30,473 Outpatients
por: Rastoder, Ema, et al.
Publicado: (2021) -
Risk of Chronic Obstructive Pulmonary Disease Exacerbation in Patients Who Use Methotrexate—A Nationwide Study of 58,580 Outpatients
por: Bergsøe, Christina Marisa, et al.
Publicado: (2021)